Related Experiment Videos

Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli

Insights

Polymyxin B and polymyxin B nonapeptide (PMBN) increase Escherichia coli membrane permeability, causing leakage of essential molecules. Polymyxin B is bactericidal, unlike PMBN, suggesting protein release contributes to its killing effect.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Polymyxins are cationic antimicrobial peptides effective against Gram-negative bacteria.
  • Understanding their mechanism of action, particularly membrane interactions, is crucial for combating antibiotic resistance.

Purpose of the Study:

  • To investigate and compare the effects of polymyxin B and polymyxin B nonapeptide (PMBN) on Escherichia coli cytoplasmic membrane permeability.
  • To elucidate the relationship between membrane permeability changes and bacterial viability.

Main Methods:

  • Treatment of E. coli with polymyxin B and PMBN.
  • Measurement of leakage of intracellular components (amino acids, uracil, K+).
  • Assessment of bacterial viability and lysis.

Main Results:

  • Both polymyxin B and PMBN induced the loss of intracellular substances from E. coli.
  • Polymyxin B promoted faster leakage rates (1.5-2 fold) compared to PMBN.
  • PMBN did not exhibit bactericidal activity, whereas polymyxin B caused rapid cell lysis and loss of viability.

Conclusions:

  • Polymyxin B's potent bactericidal activity may stem from its ability to induce significant membrane damage and release cytoplasmic proteins.
  • PMBN, while affecting membrane permeability, lacks the strong bactericidal effect of polymyxin B, indicating a differential mechanism or threshold for cell death.

Related Concept Videos